Crescita Therapeutics (TSE:CTX) Posts Earnings Results

Crescita Therapeutics (TSE:CTX) announced its quarterly earnings results on Tuesday. The company reported C($0.04) EPS for the quarter, FiscalAI reports. Crescita Therapeutics had a return on equity of 2.92% and a net margin of 2.07%.The company had revenue of C$5.96 million during the quarter.

Crescita Therapeutics Stock Performance

Shares of CTX stock opened at C$0.74 on Thursday. The company has a current ratio of 3.12, a quick ratio of 2.29 and a debt-to-equity ratio of 2.98. Crescita Therapeutics has a 12-month low of C$0.40 and a 12-month high of C$0.75. The stock has a market capitalization of C$13.77 million, a P/E ratio of 37.00 and a beta of -0.39. The firm’s 50 day moving average is C$0.55 and its 200 day moving average is C$0.49.

Crescita Therapeutics Company Profile

Crescita Therapeutics Inc is a Canadian commercial dermatology company with in-house research & development and manufacturing capabilities. The company offers a portfolio of non-prescription skincare products and early to commercial-stage prescription drug products and owns multiple proprietary drug delivery platforms that support the development of patented formulations that can facilitate the delivery of active ingredients into or through the skin. The firm generates its revenue in the form of product sales and out-licensing revenue.